BACKGROUND Helicobacter cinaedi is a rare pathogen in humans, occurring mostly in immuno-compromised patients, with a high potential for recurrence. We describe a case of a patient with lymphoma hospitalized for chemotherapy. CASE PRESENTATION At admission, the patient presented with an indolent and non-prurigenic macular rash around her implantable venous access device. Gram staining of bloo...

BACKGROUND Central venous access devices for chemotherapy are being used extensively in patients with cancer. Spontaneous fracture and migration of the catheter is uncommon. We present the uncommon occurrence of a fracture and spontaneous migration of the fragment into the internal jugular vein as a delayed complication of a central venous access catheter implanted for chemotherapy administrati...

Abstract Background Totally implantable central venous access devices (ports) have been available for over 10 years, but have not been achieved widespread use in pediatric oncology patients. Ports facilitate the administration of chemotherapy in children with cancer. Materials and Methods In this study, early complications of implantable central venous access devices in children with different ...

Selection of the proper venous access device is important to maximize patient benefit and minimize patient discomfort, morbidity, mortality, and cost. The decision of which device to use is based on whether or not the patient requires central venous access and whether the need is short-term (<6 to 8 weeks) or long-term. Short-term venous access devices include short peripheral IV catheters, mid...